Article
High expression of β-catenin contributes to the crizotinib resistant phenotype in the stem-like cell population in neuroblastoma.
Scientific reports - 4 Dec 2017
Alshareef Abdulraheem, Gupta Nidhi, Zhang Hai-Feng, Wu Chengsheng, Haque Moinul, Lai Raymond
Abstract excerpt
ALK has been identified as a novel therapeutic target in neuroblastoma (NB), but resistance to ALK inhibitors (such as crizotinib) is well recognized. We recently published that the crizotinib sensitivity in NB cells strongly correlates with the crizotinib-ALK binding, and β-catenin effectively hinders this interaction and confers crizotinib resistance. Here, we asked if these observations hold true for the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
